BridgeBio Pharma (BBIO)
(Delayed Data from NSDQ)
$27.05 USD
+0.35 (1.31%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $27.05 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -1.09 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 87.50% |
ABR | 1.21 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.20 |
Next Year | -2.84 |
EPS (TTM) | -3.07 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.30M | 8.30M | 280.52M | 265.87M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 26.10M | 26.10M | 363.00M | 554.40M |
Low Estimate | 1.50M | 1.50M | 216.47M | 127.99M |
Year ago Sales | 1.64M | 4.09M | 9.30M | 280.52M |
Year over Year Growth Est. | 406.10% | 102.93% | 2,915.34% | -5.22% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.09 | -1.05 | -3.20 | -2.84 |
# of Estimates | 6 | 4 | 7 | 6 |
Most Recent Consensus | -0.99 | -1.00 | -3.08 | -0.48 |
High Estimate | -0.82 | -0.85 | -1.42 | -0.48 |
Low Estimate | -1.27 | -1.30 | -4.07 | -3.79 |
Year ago EPS | -0.98 | -1.08 | -3.95 | -3.20 |
Year over Year Growth Est. | -11.22% | 2.78% | 18.99% | 11.17% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.09 | -1.05 | -3.20 | -2.84 |
7 Days Ago | -1.09 | -1.05 | -3.20 | -2.84 |
30 Days Ago | -1.09 | -1.05 | -3.20 | -2.84 |
60 Days Ago | -1.09 | -1.05 | -3.20 | -2.76 |
90 Days Ago | -0.83 | -0.87 | -3.09 | -2.76 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.09 | -1.05 | -3.20 | -2.84 |
Zacks Consensus Estimate | -1.09 | -1.05 | -3.20 | -2.84 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | -0.96 | -1.08 | -0.98 | NA |
Estimate | -0.40 | -0.95 | -0.86 | -0.86 | NA |
Difference | 0.35 | -0.01 | -0.22 | -0.12 | 0.00 |
Surprise | 87.50% | -1.05% | -25.58% | -13.95% | 11.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more